Where Objective Data Meets Clinical Decision-Making
Integrate neurodiagnostic testing solutions into your practice with streamlined ordering, actionable reports, and objective biological insights to support patient evaluation and longitudinal monitoring.
0
Annual TBI incidence
0%
Of standard CT scans return normal results where brain injury is clinically evident
How It Works
1. Order
Place test orders in minutes through our secure online provider portal.
2. Sample Collection Coordination
Patient samples are collected through a standard blood draw using one of three flexible options: in-clinic collection for practices with in-house phlebotomy, mobile phlebotomy, or an outpatient collection site.
3. Laboratory Analysis
Collected blood samples are returned to our CLIA-certified and CAP-accredited laboratory using the prepaid shipping label included with each test kit.
4. Results
Receive actionable, easy-to-interpret reports designed to support patient evaluation, longitudinal monitoring, and informed clinical decision-making. Results available within 7-10 business days.
How It Works
1. Order
Place test orders in minutes through our secure online provider portal.
2. Sample Collection Coordination
Patient samples are collected through a standard blood draw using one of three flexible options: in-clinic collection for practices with in-house phlebotomy, mobile phlebotomy, or an outpatient collection site.
3. Laboratory Analysis
Collected blood samples are returned to our CLIA-certified and CAP-accredited laboratory using the prepaid shipping label included with each test kit.
4. Results
Receive actionable, easy-to-interpret reports designed to support patient evaluation, longitudinal monitoring, and informed clinical decision-making. Results available within 7-10 business days.
How Our Neurodiagnostics Support Patient Care
Objective frontline neuroinjury evaluation
Recovery planning and treatment support
Longitudinal neuroinjury monitoring
Genetic risk factors
Pre- and post-intervention assessment
Medicolegal documentation
A helpful resource to print and hand out to your patients during their visit.
Explore Testing Solutions
clinical baseline
Neural-Injury Assessment Test™
Complete Panel
Protein biomarkers and genetic markers providing objective biological data on cellular injury, change, and neurological risk factors.
4 PROTEIN BIOMARKERS
GFAP • UCH-L1 • S100β • NF-H
2 GENETIC MARKERS
APOE • MTHFR
Genetic markers are evaluated once because DNA remains constant throughout life.
serial monitoring
Neural-Injury Assessment Test™
Biomarker Panel
Designed for longitudinal monitoring using protein biomarkers associated with cellular injury and change.
4 PROTEIN BIOMARKERS
GFAP • UCH-L1 • S100β • NF-H
coming soon
Neural-Injury Assessment Test™
In Development
A forthcoming panel evaluating hormones associated with neuroendocrine function and change.
clinical baseline
Neural-Injury Assessment Test™
Complete Panel
Protein biomarkers and genetic markers providing objective biological data on cellular injury, change, and neurological risk factors.
4 PROTEIN BIOMARKERS
GFAP • UCH-L1 • S100β • NF-H
2 GENETIC MARKERS
APOE • MTHFR
Genetic markers are evaluated once because DNA remains constant throughout life.
serial monitoring
Neural-Injury Assessment Test™
Biomarker Panel
Designed for longitudinal monitoring using protein biomarkers associated with cellular injury and change.
4 PROTEIN BIOMARKERS
GFAP • UCH-L1 • S100β • NF-H
coming soon
Neural-Injury Assessment Test™
In Development
A forthcoming panel evaluating hormones associated with neuroendocrine function and change.
Neurodiagnostic Testing Solutions
Objective Biological Data for Neurological Function and Change
clinical baseline
Neural-Injury Assessment Test™
Complete Panel
Protein biomarkers and genetic markers providing objective biological data on cellular injury, change, and neurological risk factors.
4 PROTEIN BIOMARKERS
GFAP • UCH-L1 • S100β • NF-H
2 GENETIC MARKERS
APOE • MTHFR
Genetic markers are evaluated once because DNA remains constant throughout life.
serial monitoring
Neural-Injury Assessment Test™
Biomarker Panel
Designed for longitudinal monitoring using protein biomarkers associated with cellular injury and change.
4 PROTEIN BIOMARKERS
GFAP • UCH-L1 • S100β • NF-H
coming soon
Neural-Injury Assessment Test™
In Development
A forthcoming panel evaluating hormones associated with neuroendocrine function and change.
clinical baseline
Neural-Injury Assessment Test™
Complete Panel
Protein biomarkers and genetic markers providing objective biological data on cellular injury, change, and neurological risk factors.
4 PROTEIN BIOMARKERS
GFAP • UCH-L1 • S100β • NF-H
2 GENETIC MARKERS
APOE • MTHFR
Genetic markers are evaluated once because DNA remains constant throughout life.
serial monitoring
Neural-Injury Assessment Test™
Biomarker Panel
Designed for longitudinal monitoring using protein biomarkers associated with cellular injury and change.
4 PROTEIN BIOMARKERS
GFAP • UCH-L1 • S100β • NF-H
coming soon
Neural-Injury Assessment Test™
In Development
A forthcoming panel evaluating hormones associated with neuroendocrine function and change.
Laboratory Credentials and Recognition
CAP-accredited
College of American Pathologists
#8647015
CLIA-certified
High-complexity clinical testing
#06D2174124
Methodology
Validated immunoassay and
PCR-based methodology
